Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel
immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable …

Neuroendocrine breast neoplasms are uncommon invasive carcinomas that have
historically been poorly defined due to various definitions of what constitutes a …

Breast cancers with neuroendocrine (NE) differentiation are very heterogeneous, comprising
broadly cancers that are morphologically similar to NE tumors (NET) of other anatomic sites …

Summary INSM1, ASCL1, and POU2F3 are novel transcription factors involved in
neuroendocrine (NE) differentiation of neoplasms in several organs, but data on their …

Purpose: The American Joint Committee on Cancer recognizes 6 rare histological variants
of prostate adenocarcinoma. We describe the contemporary presentation and overall …

Background Insulinoma-associated protein 1 (INSM1), a transcriptional regulator with a zinc-
finger DNA-binding domain, has been validated as a cytoplasmic marker for neuroendocrine …

According to the 2019 WHO classification of breast tumors, neuroendocrine neoplasms
(NENs) are classified into well-differentiated NE tumors (NET) and poorly differentiated NE …

Although most patients with pulmonary carcinoid (PC) can be cured by surgery, relapse may
occur until 15 years after resection in up to 10% of patients. This is unpredictable at the …

Generally, patients with stage I-IIIa (TNM) pulmonary carcinoid disease have a favourable
prognosis after curative resection. Yet, distant recurrence of disease after curative surgery …

Parathyroid adenomas are slow growing benign neoplasms associated with hypercalcemia,
while atypical parathyroid adenomas and parathyroid carcinomas are uncommon tumors …